Literature DB >> 11246465

Human 18 kDa phosphotyrosine protein phosphatase (ACP1) polymorphism: studies of rare variants provide evidence that substitutions within or near alternatively spliced exons affect splicing result.

L Rudbeck1, J Dissing, K D Lazaruk, G Sensabaugh.   

Abstract

The mammalian low molecular weight phosphotyrosine protein phosphatase is expressed as two distinct isoforms. The human 'fast' and 'slow' isoforms differ only in the sequence of an internal segment of 34 residues, and the ACP1 gene contains two adjacent exons (E3F and E3S) which encode these segments. We have previously suggested that the fast and slow isoforms are generated by mutually exclusive pre-mRNA splicing of E3F and E3S. The common alleles ACP1*A, *B and *C express the fast and slow isoforms in different ratios. The *A and *C alleles differ from *B by C --> T transitions in E3S and E3F respectively. To test the idea that the fast : slow ratio is determined by nucleotide substitutions in the E3F-I3F-E3S region, four groups of rare ACP1 variants with unusual fast : slow ratios and the rare *E and *R alleles, expressing fast∶slow ratios similar to *C and *B, respectively, were analysed. Gene segments of the I2-I3S region were amplified by PCR and analysed by SSCP and variant bands were excised and sequenced. For each of the rare isozymic variants one of six different nucleotide substitutions in E3F (nts+42, +85, +109, +110), I3F (nt+1) and I3S (nt+8) was observed. The *E and *R alleles showed C and B sequence, respectively, in accordance with the fast : slow ratio. The results support the hypothesis that the fast : slow ratio is constitutive.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11246465     DOI: 10.1017/S0003480000007995

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  4 in total

1.  Genes identified through genome-wide association studies of osteonecrosis in childhood acute lymphoblastic leukemia patients.

Authors:  Vincent Gagné; Anne Aubry-Morin; Maria Plesa; Rachid Abaji; Kateryna Petrykey; Pascal St-Onge; Patrick Beaulieu; Caroline Laverdière; Nathalie Alos; Jean-Marie Leclerc; Stephen E Sallan; Donna Neuberg; Jeffery L Kutok; Lewis B Silverman; Daniel Sinnett; Maja Krajinovic
Journal:  Pharmacogenomics       Date:  2019-11-05       Impact factor: 2.533

2.  European ACP1*C allele has recessive deleterious effects on early life viability.

Authors:  Jason A Wilder; Michael F Hammer
Journal:  Hum Biol       Date:  2004-12       Impact factor: 0.553

3.  Low-molecular-weight protein tyrosine phosphatase is a positive component of the fibroblast growth factor receptor signaling pathway.

Authors:  Eui Kyun Park; Neil Warner; Kathleen Mood; Tony Pawson; Ira O Daar
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

Review 4.  The role of low-molecular-weight protein tyrosine phosphatase (LMW-PTP ACP1) in oncogenesis.

Authors:  Irina Alho; Luís Costa; Manuel Bicho; Constança Coelho
Journal:  Tumour Biol       Date:  2013-04-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.